• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
48,888.32 -274.62
(-0.56%)
Dow Jones
7,157.73 -2.07
(-0.03%)
Hang Seng
59,153.23 -764.23
(-1.28%)
Nikkei 225
10,371.76 158.65
(1.55%)
Forex
USD-INR
94.52 0.35
(0.37%)
EUR-INR
110.65 0.18
(0.17%)
GBP-INR
127.71 0.18
(0.14%)
JPY-INR
0.59 0.00
(0.25%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.0814588
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
301.92
58725.49
EPS(TTM)
Face Value()
Div & Yield %
1.2
5
0.1
 

As on: Apr 30, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
359.55 -2.75 75775 301.92
Stock Price Details
Open Price() 360.05
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 361.55
Today's Low () 354.80
52-Week High () 424.95
152-Week Low () 317
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.10
Eps 1.2
Book Value 167.0814588
Market Cap (.Cr) 58,725.49
Face Value 5
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE376G01013


News
Biocon to declare Quarterly Results
Biocon receives Health Canada approval for two biosimilars - Bosaya™ and Vezuo™
Biocon rises after Health Canada grants NOC for Denosumab biosimilars
Biocon Ltd spurts 0.85%, gains for fifth straight session
Biocon Ltd rises for third consecutive session
Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon gains after receiving US FDA approval for type-2 diabetes treatment drug Dapagliflozin
Biocon launches biosimilars - Bosaya™ and Aukelso™ in U.S.
Biocon receives USFDA approval for Liraglutide
Biocon gets US FDA nod for chronic weight management drug Liraglutide
More
Corporate Details
Incoporation Year   : 1978
Chairman : Kiran Mazumdar Shaw
Bussiness Group : Indian Private
Registered Office
Biocon Ltd
20th KM Hosur Road Hebbagodi,
Electronic City P O,
Bangalore,
Karnataka-560100
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-80-28082808
Fax:91-80-28523423
Fax:91-22-66317458
E-Mail : co.secretary@biocon.com
URL : http://www.biocon.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • BSE Shariah 50
  • CNX 500
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi